enVVeno Medical (NVNO) Income from Continuing Operations (2017 - 2026)
enVVeno Medical (NVNO) recorded quarterly Income from Continuing Operations of 4040000.0 in Q1 2026, down 3.32% quarter-over-quarter from 3910000.0 in Q4 2025, and up 14.68% on a YoY basis from 3522909.76 in Q1 2025.
enVVeno Medical (NVNO) Income from Continuing Operations (2017 - 2026) Analysis & Trends
enVVeno Medical's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 4040000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 14.68% year-over-year to 4040000.0; the TTM figure through Mar 2026 stood at 19512000.0 (up 14.15% YoY), while the FY2025 annual figure was 20207000.0, up 13.78% from the prior year.
- Income from Continuing Operations was 4040000.0 for Q1 2026 at enVVeno Medical, down from 3910000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3910000.0 in Q4 2025 to a low of 6949000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 5736058.82 across 5 years, with a median of 6076000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 191.99% in 2022, then soared 40.18% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 6416000.0 in 2022, then rose by 2.96% to 6226000.0 in 2023, then dropped by 4.98% to 6536000.0 in 2024, then soared by 40.18% to 3910000.0 in 2025, then decreased by 3.32% to 4040000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 4040000.0 (Q1 2026), 3910000.0 (Q4 2025), and 4708000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | enVVeno Medical | 6.86 Mn | 6.86 Mn | - | -4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.04 Mn |
| Dec 31, 2025 | -3.91 Mn |
| Sep 30, 2025 | -4.71 Mn |
| Jun 30, 2025 | -6.85 Mn |
| Mar 31, 2025 | -4.74 Mn |
| Dec 31, 2024 | -6.54 Mn |
| Sep 30, 2024 | -6.08 Mn |
| Jun 30, 2024 | -5.38 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -5.31 Mn |
| Jun 30, 2023 | -6.78 Mn |
| Mar 31, 2023 | -6.75 Mn |
| Dec 31, 2022 | -6.42 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.95 Mn |
| Mar 31, 2022 | -5.33 Mn |
| Dec 31, 2021 | -8.99 Mn |
| Sep 30, 2021 | -2.70 Mn |
| Jun 30, 2021 | -2.38 Mn |